Compliance In Focus

In a clinical research, patients are the most important key to a study. Subject retention is vital for data integrity, and lack of subject participation can have costly delays for the Sponsor.  Since research sites spend a great deal of time and effort finding qualified subjects, they should also be equipped with reasons subjects withdraw to help prevent this from happening.

In the current issue of ACRP's The Monitor, there is an interesting article regarding a different approach for monitoring federally-funded studies.  In an effort to reduce cost and increase efficiency in regards to monitoring federally-funded studies, groups such as the Cardiovascular Cell Therapy Research Network (CCTRN) have been created.  The CCTRN was established by the National Heart, Lung, and Blood Institute (NHLBI) with the goals to “develop, coordinate, and simultaneously conduct multiple collaborate trials testing the effects of cell therapy in cardiovascular disease”.  The article states that there was a particular goal to assist in investigator-initiated studies.

The Association of Clinical Research Professionals (ACRP) is hosting their annual conference in Orlando, Florida April 13-16, 2013. The conference aims at supporting professional growth and development of individuals conducting clinical trials.  ACRP’s conference also offers an exhibition component that provides additional education and a forum for exchange and peer-to-peer engagement.

In a clinical research, patients are the most important key to a study. Subject retention is vital for data integrity, and lack of subject participation can have costly delays for the Sponsor.  Since research sites spend a great deal of time and effort finding qualified subjects, they should also be equipped with reasons subjects withdraw to help prevent this from happening.